Peripheral effects of anticholinergic psychotomimetics.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001535:Benactyzine / Q000494:pharmacology; D006016:Glycolates / Q000494:pharmacology; D006213:Hallucinogens / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007583:Jejunum / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects*; D010276:Parasympatholytics / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000037:antagonists & inhibitors*; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology
D006016:Glycolates; D006213:Hallucinogens; D010276:Parasympatholytics; D010880:Piperidines; D000644:Quaternary Ammonium Compounds; D001535:Benactyzine; D001285:Atropine; D012601:Scopolamine; D000109:Acetylcholine